Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials
NCT: NCT07541365 · NOT_YET_RECRUITING
Brief Summary
Wearable sensors offer opportunities to improve the people's experiences with cancer treatment and to improve care delivery. This is a single-arm, prospective, unblinded pilot study designed to evaluate the feasibility and acceptability of wearable sensor-based monitoring and incorporating electronic patient-reported outcomes (ePROs) in Phase I oncology clinical trials. The study will enroll participants enrolled in early phase clinical trials at the Cleveland Clinic Novel Therapeutics Clinic and aims to establish the foundation for future, larger-scale prospective studies integrating digital health technologies into early-phase cancer clinical trials. Participants will be offered a smartwatch device compatible to their phone's operating system and be guided through the installation and use of the researchers' free study mobile application. Participants already owning compatible smartwatch devices may elect to use their own smartwatch for the study.
Frequently Asked Questions
What is Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials?
Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials is a clinical trial registered under NCT07541365. Current status: NOT_YET_RECRUITING.
What is the status of NCT07541365?
The current status of NCT07541365 (Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials) is: NOT_YET_RECRUITING.
When did Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials start?
Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials started on 2026-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.